27 November 2024
27 November 2024
Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the anti-TIGIT therapy.
The new Prescription Drug User Fee Act (PDUFA) date for diazoxide choline extended-release (DCCR) is slated for 27 March 2025.
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.
Amglidia was approved by the European Medicines Agency in 2018.
Sarepta's president and CEO, Doug Ingram, is set to join the Arrowhead board of directors.
Saniona will receive an upfront payment of $28m.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
